Mendoza CU, Rodríguez GJA, Alonso BME

Language: Spanish
References: 12
Page: 338-347
PDF size: 128.92 Kb.

ABSTRACT

Objective: evaluate the association between serum levels of C-reactive protein and the indices apoprotein B/apoprotein A1, apoprotein B/LDL cholesterol, LDL/HDL cholesterol, atherogenic index, lipoprotein (a) and serum complement components C3 and C4, as well as the prediction capacity of C-reactive protein, C3 and C4 complement with respect to the above mentioned lipidogram parameters. A crosssectional study was conducted of patients with rheumatoid arthritis and healthy controls from the province of Matanzas.
Methods: individual parameters were determined by immunoturbidimetry and enzymatic colorimetry. Results were processed with the statistical software SPSS version 18.0.
Results: Spearman rank correlation spotted an association of C-reactive protein with indices ApoB/LDL cholesterol and LDL/HDL cholesterol exclusively in patients, Spearman's Rho = 0.439 (p=0.002); -0.300 (p=0.043); -0.300 (p=0.043), respectively; and an association of C-reactive protein with C4 complement in both groups, Spearman's Rho = 0.355 (p=0.015); 0.376 (p=0.000), patients and controls, respectively. C-reactive protein predicted the ApoB/LDL cholesterol index by linear regression analysis in patients: R²=0.192 F=10.488 (p=0.002), whereas C3 and C4 complement proteins significantly estimated the level of lipoprotein (a): R²=0.170 F=4.396 (p=0.018). Results support the hypothesis about the link between inflammatory response and the predominance of more proatherogenic low density lipoproteins, as well as the potential estimation of coronary risk markers related to lipoprotein metabolism based on serum levels of C-reactive protein, C3 and C4 complement in patients with rheumatoid arthritis.
Conclusions: demonstration of a direct link between the magnitude of the inflammatory response and the predominance of more proatherogenic LDL's, as well as the usefulness of markers of such a response PCR, C3 and C4 for the estimation of markers of coronary risk ApoB/LDLc and Lp(a) in patients with rheumatoid arthritis, suggest an evaluation of the association between the lipidogram parameters studied and more specific markers of vascular activity and dysfunction in this disease.

REFERENCES

1. Tracey E T, Vasileios F, and Kitas GD. Dyslipidaemia in Rheumatological Autoinmune Autoimmune Diseases. Open Cardiovasc Med J. 2011, 5: 64-75.

2. Sidiropoulos PI, Karvounaris SA, and Boumpas DT. Metabolic Syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications. Arthritis Res Ther. 2008, 10(3):207-28.

3. Wallach J. Interpretación clínica de las pruebas de laboratorio. Ciudad de La Habana: Editorial Ciencias Médicas, 2006:142.

4. Gómez A. Nuevos criterios de clasificación de la arthritis reumatoide. Reumatología clínica. 2011;6(s3): 33-7.

5. Lain B, Mclnnes FR, and Schett G. The pathogenesis of Rheumatoid Arthritis. Nw Eng J Med. 2011; 365:2205-19.

6. Choy E, Sattar N. Interpreting lipid levels in the context of high-grade inflammatory states with focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis. 2009; 68:460-9.

7. Schimmel EK, Yazici Y. Increased lipid levels but unchanged atherogenic index in rheumatoid arthritis patients treated with biologic disease modifying antirheumatic drugs: published experience. Ann Rheum Dis. 2009; 68: 501-8.

8. Loscalzo J. Lipoprotein (a). A unique risk factor for atherothrombotic disease. Arteriosclerosis. 1990; 10:672-9.

9. Rantapää S, Wallberg S, Dahlén G. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 1991; 50: 366-8.

10. Van Halm VP, Nielen M, Nurmohamed M, Van D, Reesink HW, Voskuyl AE, et. al. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Annals of the Rheumatic Diseases. 2007; 66: 184-8.

11. Dieplinger B, Lingenhel A, Baumgartner N, Poelz W, Dieplinger H, Haltmayer M, et. al. Increased serum Lipoprotein (a) concentrations and low molecular weight phenotypes of Apolipoprotein (a) are associated with symptomatic peripheral arterial disease. Clinical Chemistry. 2007; 53: 1298-305.

12. Libby P. Principios de Medicina Interna. Harrison. En su: La PCR en el Sistema Cardiovascular. Editorial 15a edición, 2001.